SCHEMBL3941920

SCHEMBL3941920

CN1CCN(NC(=O)Oc2[nH]c3ccc([N+](=O)[O-])cc3c2-c2ccccc2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.52
KMT2A Q03164 6/20 0.50
MEN1 O00255 5/20 0.50
FASN P49327 1/20 0.46
ALDH1A1 P00352 4/20 0.42
LMNA P02545 2/20 0.42
GAA P10253 2/20 0.42
HRH4 Q9H3N8 2/20 0.42
CSF1R P07333 1/20 0.42
KDM4E B2RXH2 1/20 0.42
MAPK1 P28482 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
BAZ2B Q9UIF8 1/20 0.41
F2RL3 Q96RI0 3/20 0.40
POLB P06746 2/20 0.40
PKM P14618 1/20 0.40
NPY1R P25929 1/20 0.40
NPY2R P49146 1/20 0.40
F2R P25116 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3946744 0.85 LIPE (0.41) MAPTKMT2AMEN1ALDH1A1GAA
SCHEMBL4926701 0.84 KMT2A (0.66) MAPTKMT2AMEN1FASNALDH1A1
SCHEMBL3948652 0.80 MAPT (0.60) MAPTKMT2AMEN1FASNALDH1A1
SCHEMBL3945148 0.80 MAPT (0.56) MAPTKMT2AMEN1FASNALDH1A1
SCHEMBL3944806 0.80 MAPT (0.67) MAPTKMT2AMEN1FASNALDH1A1
SCHEMBL3942382 0.79 MEN1 (0.56) MAPTKMT2AMEN1FASNALDH1A1
SCHEMBL3950577 0.78 LMNA (0.49) MAPTKMT2AMEN1FASNALDH1A1
SCHEMBL3945036 0.77 MAPT (0.53) MAPTKMT2AMEN1FASNALDH1A1
SCHEMBL3941693 0.77 BRD4 (0.49) KMT2AMEN1ALDH1A1POLBNPSR1
SCHEMBL3947479 0.77 MEN1 (0.53) MAPTKMT2AMEN1FASNALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1802572-B1 INDOL DERIVATIVES AS INHIBITORS OF SOLUBLE ADENYLYL CYCLASE BAYER SCHERING PHARMA AG (DE) 2009-04-22 EP disclosed
EP-1802572-A1 INDOL DERIVATIVES AS INHIBITORS OF SOLUBLE ADENYLYL CYCLASE Bayer Schering Pharma Aktiengesellschaft (DE) 2007-07-04 EP disclosed
WO-2006032541-A1 INDOL DERIVATIVES AS INHIBITORS OF SOLUBLE ADENYLYL CYCLASE BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2006-03-30 WO disclosed